Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Curr Opin Neurobiol. 2011 Oct 10;22(3):488–495. doi: 10.1016/j.conb.2011.09.005

The regulation of glutamate receptor trafficking and function by TARPs and other transmembrane auxiliary subunits

Christoph Straub 1, Susumu Tomita 1,
PMCID: PMC3265624  NIHMSID: NIHMS330802  PMID: 21993243

Abstract

At excitatory synapses in the brain, glutamate released from nerve terminals binds to glutamate receptors to mediate signaling between neurons. Glutamate receptors expressed in heterologous cells show ion channel activity. Recently, native glutamate receptors were shown to contain auxiliary subunits that modulate the trafficking and/or channel properties. The AMPA receptor (AMPAR) can contain TARP and CNIHs as the auxiliary subunits, whereas kainate receptor (KAR) can contain the Neto auxiliary subunit. Each of these auxiliary subunits uniquely modulates the glutamate receptors, and determines properties of native glutamate receptors. A thorough elucidation of the properties of native glutamate receptor complexes is indispensable for the understanding of the molecular machinery that regulates glutamate receptors and excitatory synaptic transmission in the brain.

Introduction

Neurons connect with each other physically and functionally to form neuronal circuits. Neurons communicate mainly at synapses via chemical neurotransmission. The principal excitatory neurotransmitter in the vertebrate brain is glutamate. Glutamate released from presynaptic terminals binds to postsynaptic ionotropic glutamate receptors (iGluRs) to depolarize postsynaptic membranes. The spatial and temporal summation of postsynaptic depolarizations then may generate action potentials in the postsynaptic neuron that transmit information to subsequent neurons in the neuronal circuit. The strength and pattern of synaptic transmission are crucial factors for the proper function of neuronal connections. Synaptic strength is mediated by changes in the concentration of glutamate in the synaptic cleft, as well as by the number and channel properties of glutamate receptors. Thus, it is important to understand the physiological mechanisms that govern glutamate receptor abundance and functional properties at synapses.

Glutamate receptors and auxiliary subunits

Ionotropic glutamate receptors (iGluRs) are classified, using pharmacology, into three types: the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-, the N-methyl-D-aspartate (NMDA)-, and the kainate (KA)-type [1-3]. When expressed in heterologous cells, the iGluRs show glutamate-dependent ion channel activity, and their expression alone is sufficient to form a channel pore. However, native iGluRs also contain auxiliary subunits, which modulate the trafficking and/or the channel properties of the receptors. Several molecules have been proposed to be auxiliary subunits of iGluRs; these include the Transmembrane AMPA receptor Regulatory proteins (TARPs), the Cornichon-like proteins (CNIHs), and the Neuropilin and Tolloid like proteins (Netos) [4-6]. The current review summarizes recent progress, with emphasis on papers published in the past two years, in understanding the regulation of iGluRs by the TARP, CNIH2/3, and Neto auxiliary subunits.

TARPs and CNIH2/3 regulate AMPAR trafficking and function

At synapses, the number and channel properties of AMPARs must be controlled in basal transmission and regulated upon neuronal activity. The AMPAR auxiliary subunits, TARPs and CNIH2/3, are important for the regulation of AMPAR activity at synapses. CNIH2 and CNIH3, but not CNIH1 or CNIH4, have been shown to bind to AMPARs [7]. Based upon characteristic features in their modulation of channel properties and/or trafficking of AMPARs, the six TARP isoforms are classified as type 1a (γ-2/stargazin and γ-3), type 1b (γ-4 and γ-8), and type 2 (γ-5 and γ-7) TARPs [8,9].

TARPs regulate AMPA receptor numbers at synapses

TARPs stabilize AMPARs at synapses via direct interactions with the post-synaptic density (PSD)-enriched PSD-95 and other MAGUKs (Figure 1) [4-6,10-12]. TARPs can be co-purified with AMPA receptors from the brain [13-15], and the c-terminal PDZ binding motifs of the TARPs directly interact with the PDZ domains of PSD-95 or other MAGUKs [16,17]. This interaction was shown to be necessary for synaptic AMPAR function by measuring AMPAR-mediated excitatory post-synaptic currents (EPSCs) following PDZ-domain mutation [18], and by acute disruption of the interaction between TARPs and PSD-95 using biomimetic divalent ligands [19].

Figure 1. Trafficking of Glutamate Receptor Complexes.

Figure 1

(a) Schematic domain structure of pore-forming subunits and auxiliary subunits, ATD (amino terminal domain), LBD (ligand binding domain, CUB (Complement C1r/C1s, Uegf, Bmp1 domain), LDL (LDL-receptor class A domain), and globular structure at C-terminus indicates PDZ binding motif. (b) AMPAR associates with CNIH and TARPs in hippocampus, and TARPs mediate surface expression and synaptic localization of AMPAR complex (red arrows). The AMPAR complex is stabilized at postsynaptic density (PSD) via interaction of the TARP PDZ ligand with the PDZ domain of PSD-95. Phosphorylated TARPs dissociate from negatively-charged lipid bilayers and interact with PSD-95, whereas non-phosphorylated TARPs associate with negatively-charged lipid bilayers and stays at extrasynaptic sites. (c) Surface expression of KAR complex depends on low-affinity GluK1/2/3 KAR subunits (blue arrow), and the mechanism of synaptic targeting for KAR complex is unknown.

The six isoforms of TARPs display distinct distributions in the brain [8,20]. A loss or reduction in the AMPAR-mediated EPSCs is observed in cerebellar granule cells and stellate cells from stargazer mice carrying a disrupted γ-2/stargazin gene, in cerebellar Golgi cells from ©2/γ-3 double knockout mice (KO), in hippocampal pyramidal cells from γ-8 KO, and in Purkinje cells from γ-2/γ-7 double KO mice [21-25]. AMPA-evoked whole cell currents in the hippocampal neurons from γ-8 KOs were reduced to 10% of wild-type levels [22]. Importantly, severe reductions in AMPAR expression are also observed in the hippocampus of γ-8 KO mice [22,26], a similar phenotype to that observed in mice lacking the GluA1 AMPAR subunit (GluA1 KO) [27]. These similarities indicate that the reduction of AMPAR activity in γ-8 KO mice may result from the loss of the γ-8 or indirectly from the severe reduction in AMPAR expression. To discern between these possibilities, γ-8 knock-in (KI) mice lacking the c-terminal PDZ binding motif (TTPV; γ-8⊗) were generated [28]. In the γ-8Δ4 KI mice, both AMPAR-mediated EPSCs and synaptic AMPAR protein levels were reduced to a similar extent as those observed in γ-8 KO mice, despite a slight reduction in total AMPAR expression [28]. These results suggest that the four c-terminal amino acids of the γ-8 (-TTPV) regulate the abundance of synaptic AMPAR, and the remainder of the γ-8 protein stabilizes AMPAR expression in the brain [28].

Importantly, 70% of AMPAR-mediated EPSCs were still detected in the γ-8 KO and the γ-8Δ4 KI mice [22,28]. As hippocampal CA1 pyramidal cells also express the γ-2/3/4 TARPs [8,20], it remains unclear whether or not all AMPAR at synapses require binding to TARPs for normal function. Triple KOs of γ-2/3/4, γ-2/3/8 and γ-2/4/8 are lethal at early developmental stage [29], therefore region-specific conditional TARP KO mice will be useful to study the contribution of TARPs to AMPAR-mediated neurotransmission in the adult brain.

Lipid molecules have been identified to modulate the synaptic localization of the AMPAR/TARP complex (Figure 1). Negatively-charged lipids and lipid bilayers interact with positively-charged arginine clustered regions in the TARP cytoplasmic domain [30]. Electron crystallographic reconstruction of recombinant γ-2 revealed the c-terminal interaction of TARPs with lipid bilayers [31]. Interestingly, lipid interactions with TARPs inhibit the binding of TARPs to PSD-95 [30]. Furthermore, TARPs are phosphorylated in the brain [32,33], and TARP phosphorylation inhibits its ability to interact with lipids, and is followed by the localization of the AMPAR/TARP complex to the synapse [30]. The γ-2 phospho (all nine phosphorylatable serine residues to aspartic acid) and non-phospho (all nine phosphorylatable serine residues to alanine) knockin mice were generated [30]. The amplitudes of AMPAR-mediated EPSCs at cerebellar mossy fiber-granule cell synapses are larger in γ-2 phospho-mimic KI mice (stargazinSD) than in γ-2 nonphospho-mimic KI mice (stargazinSA) [30]. In primary cultured neurons, phospho-mimic γ-2 is more stable than non-phospho-mimic γ-2 [28,34]. However, γ-8Δ4 KI mice showed reduction in AMPAR-mediated EPSCs in basal transmission, but no changes in LTP [28]. This result suggests that the PDZ binding motif on TARPs is not required for LTP. Another modulation, the calpain-mediated cleavage of the TARP cytoplasmic domain upon NMDA stimulation, has been demonstrated [35]. Therefore, the post-translational modification of TARPs might contribute to their ability to modulate synaptic strength.

TARPs regulate channel properties of AMPA receptors

In addition to the modulation of AMPAR localization, TARPs regulate the channel properties of AMPARs (Figure 2) [4-6,10-12]. The presence of TARPs slows the kinetics of AMPAR deactivation (channel closure upon glutamate removal) and desensitization (channel closure upon glutamate binding) [36-38]. Stargazer mice (γ-2stg/stg) show no AMPAR activity at cerebellar mossy fiber - granule cell synapses, and no miniature EPSCs (mEPSCs) was observed in primary cerebellar granule cell cultures [16,21]. Overexpression of type I TARPs (γ-2/stargazin, γ-3, γ-4, and γ-8) restores mEPSCs in primary cerebellar granule cells cultures from Stargazer [8,16].

Figure 2. Modulation of Channel Kinetics by Auxiliary Subunits.

Figure 2

(a, b): In heterologous cells, TARPs and Neto2 slow both deactivation and desensitization of AMPAR (a) and KAR (b), respectively. However, each isoform of auxiliary subunits modulates channel kinetics at different degree. Bottom panel: At the cerebellar mossy fiber - granule cell synapses, AMPAR-mediated EPSCs are absent in Stargazer-mice (γ-2stg/stg) (c), due to loss of AMPARs at synapses. On the other hand, overexpression of various TARP isoforms rescued loss of mEPSCs in stargazer granule cells with distinct mEPSC kinetics, demonstrating that decay kinetics of synaptic AMPAR is also controlled by TARPs as synaptic localization (c). In contrast, Neto1 KO mice show KAR-mediated EPSCs at mossy fiber - CA3 pyramidal cells. However, decay kinetics of KAR-mediated EPSCs is significantly fastened in Neto1 KO mice (d). Schematic drawings are modified from publications [39,67].

However, the decay kinetics of mEPSCs in neurons expressing type Ia TARPs (γ-2 and γ-3) are faster than those in neurons expressing type Ib TARPs (γ-4 and γ-8) [39,40]. This isoform-specific modulation of AMPAR kinetics is also observed in heterologous cells [39,40]. In addition, TARPs also modulate ion permeability of AMPARs. The presence of TARPs reduces the rectification of AMPARs, rendering them more calcium permeable [25,39,41,42]. TARPs are also involved in CaMKII-mediated modulation of AMPAR conductance [43].

TARPs also modulate the pharmacology of AMPARs. TARPs make the AMPAR partial agonist, kainate, more efficacious in heterologous cells, and similar kainate pharmacology was observed for native, neuronal AMPAR [36,37,44]. Potentiators of AMPAR represent a class of reagents that increase AMPAR signaling by blocking channel closure. TARPs alter the affinity and efficacy of AMPAR potentiators such as cyclothiazide, PEPA, and CX546 [45,46]. In addition, TARPs alter the actions of CNQX from those of a competitive AMPAR antagonist, to those of a partial agonist [47,48]. Kainate, cyclothiazide, and CNQX bind to the extracellular domain of AMPARs; this binding localization suggests that the modulatory effects of TARPs may also occur at the extracellular domains of AMPARs. In support of this concept, the extracellular loop 1 of TARP has been shown to be both necessary and sufficient for the modulation of AMPAR kinetics [36,39,40,49]. On the other hand, the γ-2/stargazin cytoplasmic domain was shown to mediate surface expression of AMPAR/TARP complex [36], and other studies have also recently shown that the cytoplasmic domains of some TARP isoforms modulate AMPAR properties [50,51]. In addition to affecting the properties of pharmacological reagents that bind to the AMPAR extracellular domain, TARPs modulate the actions of the AMPAR blocker, philanthotoxin-74, which presumably binds near the channel pore [52]. Interestingly, TARPs have been shown to functionally uncouple from AMPARs upon AMPAR desensitization, which auto-inactivates the AMPAR/TARP complex [53]. However, since this modulation is reversible, AMPAR/TARPs are unlikely to be physically dissociated; rather they are functionally decoupled without dissociation. Future structural studies will be necessary to reveal the precise molecular movements of the AMPAR/TARP complex upon agonist or antagonist binding.

Roles of CNIH2/3 in regulating AMPA receptors in the brain

CNIH2/3 were identified by proteomic analysis of native AMPAR complexes [7]. The expression of CNIH2/3 is substantially reduced in the hippocampus of γ-8 KO mice, and the CNIH2/3 protein can be co-immunoprecipitated with AMPARs with the use of an anti-TARP antibody [54]. These results suggest that CNIH2/3 forms a tripartite complex with AMPAR and γ-8 in the hippocampus, and that γ-8 stabilizes the CNIH/AMPAR complex in this brain region (Figure 1). Although CNIH2 expression enhances the surface expression of AMPARs in heterologous cells [7], the surface expression of CNIH2 is reduced in the hippocampus of γ-8 KO mice [55]. One interpretation of these results is that CNIH2/3 drives AMPAR to the cell surface, where γ-8 stabilizes the CNIH/AMPAR complex. Alternatively, CNIH2/3 might enhance AMPAR trafficking to the cell surface in heterologous cells, but not in hippocampal neurons. Further analysis of CNIH2/3 KO mice is needed to distinguish these two possibilities.

In a similar manner to the TARPs, CNIH2 slow AMPAR decay kinetics and alters the pharmacology of kainate and AMPAR potentiators [7,54,56,57]. Furthermore, CNIH2 modulates the decay kinetics of the AMPAR/TARPγ-8 complex [54,56]. Overexpression of CNIH2 alone in stargazer granule cells did not restore AMPAR-mediated mEPSCs [54,56], whereas the co-expression of CNIH2 together with γ-8 did restore AMPAR-mediated mEPSCs [54]. Cells co-expressing CNIH2 and γ-8 had slower mEPSC decay kinetics than cells expressing γ-8 alone [54]. In addition, CNIH2 expression is reduced in the PSD fraction of hippocampi from γ-8Δ4 KI mice, which lack AMPARs at the synapse [28]. In contrast, CNIH2 overexpression did not alter mEPSC kinetics from neurons expressing γ-2/stargazin [56]. The discrepancy between the actions of CNIH2 on mEPSC kinetics in neurons expressing γ-2 vs. γ-8 remains unexplained. It is possible that CNIH2/3 differentially modulates channel properties of AMPARs with the different TARP isoforms. A systematic analysis of the CNIH modulation of various combinations of AMPAR subunits and TARP isoforms should be conducted.

CNIH2/3 has also been shown to regulate the assembly and stoichiometry of native AMPAR complexes in the hippocampus. The numbers of TARP on each AMPAR varies depending on the expression levels of TARPs in heterologous cells [58,59]. Biochemical studies have shown that there may be one to four TARP molecules per each AMPAR tetramer in heterologous cells, whereas native AMPAR complex contains a minimum of one TARP [59]. On the other hand, one functional study showed that native AMPAR complexes may contain 2 to 4 TARP molecules, and the TARP stoichiometry was variable between neurons [56]. AMPARs containing four γ-8 molecules have unique channel properties, e.g., resensitization, which was not observed in native AMPAR complex in hippocampal CA1 pyramidal cells, indicating that the AMPARs in the hippocampal CA1 pyramidal cells typically contain fewer than four γ-8 molecules [54,55]. In the tripartite complex formed by CNIH2/AMPAR/TARP [54], CNIH2 and TARPs show a competitive interaction with the AMPAR [55]. These results indicate that CNIH2/3 may displace TARPs on AMPARs to control TARP stoichiometry. Further analysis of CNIH2/3 KO mice will likely elucidate the roles of CNIH proteins in AMPAR function.

Do all AMPARs in the brain contain TARPs or CNIHs? Comparison of molecular weight of AMPAR complex in cerebella from wild type and stargazer mice using BN-PAGE showed that almost all AMPARs in wild type cerebellum contain γ-2/stargazin [59,60]. On the other hand, antibody shift assay on BN-PAGE showed that anti γ-2/3 antibody only shift 30% of native AMPAR in hippocampus, whereas anti CNIH2/3 antibody shifted almost all AMPARs except AMPAR associated with γ-2/3 [7]. This result indicates that CNIH2/3 and γ-2/3 form distinct complex with AMPARs. However, CNIH2 was shown to form a tripartite complex with AMPAR and γ-8 in hippocampus [54]. Therefore, it remains still unclear what % of AMPAR contains TARPs or CNIHs in hippocampus and other brain regions.

Roles of Neto auxiliary subunits in KAR function

In comparison with the AMPAR and NMDAR, the KAR exhibits very slow decay kinetics and a distinct distribution revealed by [3H] kainate binding in the brain [61-63].

The Neto2 protein was identified as an auxiliary subunit of KARs by the biochemical purification of the KAR complex using anti-KAR antibodies from cerebella [64]. The presence of Neto2 slows the decay kinetics of KARs expressed heterlologously (Figure 2) [64-66]. Unlike the modulation of AMPAR trafficking by the TARPs, the presence of the GluK2 subunit of the KAR enhances the surface expression of Neto2 in the brain and in cRNA-injected oocytes, whereas Neto2 does not enhance the surface expression of GluK2 in cRNA-injected oocytes (Figure 1) [64]. However, Neto2 was found to enhance the surface expression of the GluK1 subunit in transfected HEK cells [65]. The surface expression of different KAR isoforms should be examined in Neto2 KO mice to determine the specific effects of Neto2 on KAR trafficking.

The Neto2 homologue, Neto1, also slows the decay kinetics of GluK2-containing KARs expressed in heterologous cells, but these kinetics are still faster than those of native KAR-mediated EPSCs at hippocampal mossy fiber-CA3 pyramidal cell synapses [67]. These results indicate that the expression solely of Neto1/2 and GluK2 is not sufficient to reconstruct native KARs. However, the decay kinetics of KAR-mediated EPSCs in Neto1 KO mice are similar to those of native AMPARs [67,68], suggesting that Neto1 is required for the slow decay kinetics characteristic of native KARs [61,62].

In the hippocampus stratum lucidum, where mossy fibers form synapses with CA3 pyramidal neurons, a strong signal for [3H] kainate binding is observed [63]. This signal is completely abolished in GluK2 KO mice [69] and is also substantially reduced in Neto1 KO mice without any change in GluK2 distribution [67]. These findings indicate that Neto1 may determine the [3H] kainate-binding characteristics, but not the distribution, of the KAR. Indeed, Neto1 modulates the kainate-binding affinity of KARs in the brain and in heterologous cells expressing GluK2 and GluK5 [67]. The molecular mechanisms by which KARs are stabilized at synapses remains unclear, and future studies will be needed to address this important question.

Conclusions

The different auxiliary subunits of the iGluRs play distinct roles in their trafficking and function. The TARPs modulate both the trafficking and the channel properties of AMPARs, whereas the Netos and CNIH2/3 modulate the channel properties of KARs and AMPARs, respectively. The identification of novel auxiliary subunits is rapidly expanding out knowledge of the molecular machinery that regulated iGluRs in the brain. However, numerous questions remain unanswered. For example, what roles do these subunits play in LTP? How does KAR localize to the synapse? The AMPAR and KAR both have auxiliary subunits; does NMDAR have one? By combining the power of various experimental approaches, the molecular mechanisms that underlie glutamatergic synaptic transmission will be elucidated hopefully soon.

Highlights.

>Native glutamate receptors contain pore subunits and auxiliary subunits.

>Different glutamate receptors bind to distinct auxiliary subunits.

>Auxiliary subunits modulate trafficking and/or channel properties.

>Each of the auxiliary subunits uniquely modulates glutamate receptors.

Box1: Components of Native Receptor Complexes.

Native ionotropic receptor complexes consist of two principal types of subunits.

>Pore subunit form a channel pore by itself, and line the pathway for ion flow.

>Auxiliary subunits associate directly and stably with pore subunits, and modulate their trafficking and/or channel properties.

Acknowledgement

The authors thank members of the Tomita lab for helpful discussions. S.T. is supported by NIH MH077939 and MH085080. C.S. is supported by a Boehringer-Ingelheim Fonds PhD fellowship.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References and recommended reading

  • 1.Hollmann M, Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci. 1994;17:31–108. doi: 10.1146/annurev.ne.17.030194.000335. [DOI] [PubMed] [Google Scholar]
  • 2.Wisden W, Seeburg PH. Mammalian ionotropic glutamate receptors. Current Opinion in Neurobiology. 1993;3:291–298. doi: 10.1016/0959-4388(93)90120-n. [DOI] [PubMed] [Google Scholar]
  • 3.Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science. 1992;258:597–603. doi: 10.1126/science.1329206. [DOI] [PubMed] [Google Scholar]
  • 4.Jackson AC, Nicoll RA. The Expanding Social Network of Ionotropic Glutamate Receptors: TARPs and Other Transmembrane Auxiliary Subunits. Neuron. 2011;70:178–199. doi: 10.1016/j.neuron.2011.04.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Diaz E. Regulation of AMPA receptors by transmembrane accessory proteins. Eur J Neurosci. 2010;32:261–268. doi: 10.1111/j.1460-9568.2010.07357.x. [DOI] [PubMed] [Google Scholar]
  • 6.Tomita S. Regulation of ionotropic glutamate receptors by their auxiliary subunits. Physiology (Bethesda) 2010;25:41–49. doi: 10.1152/physiol.00033.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • **7.Schwenk J, Harmel N, Zolles G, Bildl W, Kulik A, Heimrich B, Chisaka O, Jonas P, Schulte U, Fakler B, et al. Functional proteomics identify cornichon proteins as auxiliary subunits of AMPA receptors. Science. 2009;323:1313–1319. doi: 10.1126/science.1167852. [This paper identified Cornichon-like proteins (CNIH2/3) in native AMPAR complex. Furthermore, this paper showed that CNIH2/3 form distinct AMPAR complex from the AMPAR/TARP complex, and CNIH2 slows decay kinetics of AMPARs in heterologous cells.] [DOI] [PubMed] [Google Scholar]
  • 8.Tomita S, Chen L, Kawasaki Y, Petralia RS, Wenthold RJ, Nicoll RA, Bredt DS. Functional studies and distribution define a family of transmembrane AMPA receptor regulatory proteins. J Cell Biol. 2003;161:805–816. doi: 10.1083/jcb.200212116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kato AS, Siuda ER, Nisenbaum ES, Bredt DS. AMPA receptor subunit-specific regulation by a distinct family of type II TARPs. Neuron. 2008;59:986–996. doi: 10.1016/j.neuron.2008.07.034. [DOI] [PubMed] [Google Scholar]
  • 10.Opazo P, Choquet D. A three-step model for the synaptic recruitment of AMPA receptors. Mol Cell Neurosci. 2011;46:1–8. doi: 10.1016/j.mcn.2010.08.014. [DOI] [PubMed] [Google Scholar]
  • 11.Kato AS, Gill MB, Yu H, Nisenbaum ES, Bredt DS. TARPs differentially decorate AMPA receptors to specify neuropharmacology. Trends Neurosci. 2010;33:241–248. doi: 10.1016/j.tins.2010.02.004. [DOI] [PubMed] [Google Scholar]
  • 12.Coombs ID, Cull-Candy SG. Transmembrane AMPA receptor regulatory proteins and AMPA receptor function in the cerebellum. Neuroscience. 2009;162:656–665. doi: 10.1016/j.neuroscience.2009.01.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Tomita S, Fukata M, Nicoll RA, Bredt DS. Dynamic interaction of stargazin-like TARPs with cycling AMPA receptors at synapses. Science. 2004;303:1508–1511. doi: 10.1126/science.1090262. [DOI] [PubMed] [Google Scholar]
  • 14.Fukata Y, Tzingounis AV, Trinidad JC, Fukata M, Burlingame AL, Nicoll RA, Bredt DS. Molecular constituents of neuronal AMPA receptors. J Cell Biol. 2005;169:399–404. doi: 10.1083/jcb.200501121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Nakagawa T, Cheng Y, Ramm E, Sheng M, Walz T. Structure and different conformational states of native AMPA receptor complexes. Nature. 2005;433:545–549. doi: 10.1038/nature03328. [DOI] [PubMed] [Google Scholar]
  • 16.Chen L, Chetkovich DM, Petralia RS, Sweeney NT, Kawasaki Y, Wenthold RJ, Bredt DS, Nicoll RA. Stargazin regulates synaptic targeting of AMPA receptors by two distinct mechanisms. Nature. 2000;408:936–943. doi: 10.1038/35050030. [DOI] [PubMed] [Google Scholar]
  • 17.Dakoji S, Tomita S, Karimzadegan S, Nicoll RA, Bredt DS. Interaction of transmembrane AMPA receptor regulatory proteins with multiple membrane associated guanylate kinases. Neuropharmacology. 2003;45:849–856. doi: 10.1016/s0028-3908(03)00267-3. [DOI] [PubMed] [Google Scholar]
  • 18.Schnell E, Sizemore M, Karimzadegan S, Chen L, Bredt DS, Nicoll RA. Direct interactions between PSD-95 and stargazin control synaptic AMPA receptor number. Proc Natl Acad Sci U S A. 2002;99:13902–13907. doi: 10.1073/pnas.172511199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • **19.Sainlos M, Tigaret C, Poujol C, Olivier NB, Bard L, Breillat C, Thiolon K, Choquet D, Imperiali B. Biomimetic divalent ligands for the acute disruption of synaptic AMPAR stabilization. Nat Chem Biol. 2011;7:81–91. doi: 10.1038/nchembio.498. [This paper developed a novel pharmacological reagent, which acutely disrupts interaction between TARPs and PSD-95.] [DOI] [PubMed] [Google Scholar]
  • 20.Fukaya M, Yamazaki M, Sakimura K, Watanabe M. Spatial diversity in gene expression for VDCCgamma subunit family in developing and adult mouse brains. Neurosci Res. 2005;53:376–383. doi: 10.1016/j.neures.2005.08.009. [DOI] [PubMed] [Google Scholar]
  • 21.Hashimoto K, Fukaya M, Qiao X, Sakimura K, Watanabe M, Kano M. Impairment of AMPA receptor function in cerebellar granule cells of ataxic mutant mouse stargazer. J Neurosci. 1999;19:6027–6036. doi: 10.1523/JNEUROSCI.19-14-06027.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Rouach N, Byrd K, Petralia RS, Elias GM, Adesnik H, Tomita S, Karimzadegan S, Kealey C, Bredt DS, Nicoll RA. TARP gamma-8 controls hippocampal AMPA receptor number, distribution and synaptic plasticity. Nat Neurosci. 2005;8:1525–1533. doi: 10.1038/nn1551. [DOI] [PubMed] [Google Scholar]
  • 23.Yamazaki M, Fukaya M, Hashimoto K, Yamasaki M, Tsujita M, Itakura M, Abe M, Natsume R, Takahashi M, Kano M, et al. TARPs gamma-2 and gamma-7 are essential for AMPA receptor expression in the cerebellum. Eur J Neurosci. 2010;31:2204–2220. doi: 10.1111/j.1460-9568.2010.07254.x. [DOI] [PubMed] [Google Scholar]
  • 24.Menuz K, O'Brien JL, Karmizadegan S, Bredt DS, Nicoll RA. TARP redundancy is critical for maintaining AMPA receptor function. J Neurosci. 2008;28:8740–8746. doi: 10.1523/JNEUROSCI.1319-08.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • *25.Jackson AC, Nicoll RA. Stargazin (TARP gamma-2) is required for compartment-specific AMPA receptor trafficking and synaptic plasticity in cerebellar stellate cells. J Neurosci. 2011;31:3939–3952. doi: 10.1523/JNEUROSCI.5134-10.2011. [This paper found different effects of γ-2/stargazin on synaptic and extrasynaptic AMPARs.] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Fukaya M, Tsujita M, Yamazaki M, Kushiya E, Abe K, Natsume R, Kano M, Kamiya H, Watanabe M, Sakimura K. Abundant distribution of TARP gamma-8 in synaptic and extrasynaptic surface of hippocampal neurons and its major role in AMPA receptor expression on spines and dendrites. Eur J Neurosci. 2006;24:2177–2190. doi: 10.1111/j.1460-9568.2006.05081.x. [DOI] [PubMed] [Google Scholar]
  • 27.Zamanillo D, Sprengel R, Hvalby O, Jensen V, Burnashev N, Rozov A, Kaiser KM, Koster HJ, Borchardt T, Worley P, et al. Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. Science. 1999;284:1805–1811. doi: 10.1126/science.284.5421.1805. [DOI] [PubMed] [Google Scholar]
  • 28.Sumioka A. PDZ binding of TARPγ-8 controls synaptic transmission, but not synaptic plasticity. Nat Neurosci. 2011 doi: 10.1038/nn.2952. in press. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Menuz K, Kerchner GA, O'Brien JL, Nicoll RA. Critical role for TARPs in early development despite broad functional redundancy. Neuropharmacology. 2009;56:22–29. doi: 10.1016/j.neuropharm.2008.06.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • **30.Sumioka A, Yan D, Tomita S. TARP phosphorylation regulates synaptic AMPA receptors through lipid bilayers. Neuron. 2010;66:755–767. doi: 10.1016/j.neuron.2010.04.035. [This paper first identified that TARP interacts with lipid bilayers in a TARP phosphorylation manner. The lipid interaction with TARPs inhibited TARP binding to PSD-95. Furthermore, AMPARs at cerebellar mossy fiber - granule cell synapses are regulated by TARP phosphorylation and the lipid interaction using TARP phospho knockin mice.] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Roberts MF, Taylor DW, Unger VM. Two modes of interaction between the membrane-embedded TARP stargazin's C-terminal domain and the bilayer visualized by electron crystallography. J Struct Biol. 2011;174:542–551. doi: 10.1016/j.jsb.2011.03.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Tomita S, Stein V, Stocker TJ, Nicoll RA, Bredt DS. Bidirectional synaptic plasticity regulated by phosphorylation of stargazin-like TARPs. Neuron. 2005;45:269–277. doi: 10.1016/j.neuron.2005.01.009. [DOI] [PubMed] [Google Scholar]
  • 33.Inamura M, Itakura M, Okamoto H, Hoka S, Mizoguchi A, Fukazawa Y, Shigemoto R, Yamamori S, Takahashi M. Differential localization and regulation of stargazin-like protein, gamma-8 and stargazin in the plasma membrane of hippocampal and cortical neurons. Neurosci Res. 2006;55:45–53. doi: 10.1016/j.neures.2006.01.004. [DOI] [PubMed] [Google Scholar]
  • *34.Opazo P, Labrecque S, Tigaret CM, Frouin A, Wiseman PW, De Koninck P, Choquet D. CaMKII triggers the diffusional trapping of surface AMPARs through phosphorylation of stargazin. Neuron. 2010;67:239–252. doi: 10.1016/j.neuron.2010.06.007. [This paper showed that CaMKII activity and chemical LTP modulate lateral diffusion of AMPAR through the PDZ ligand and phosphorylation of TARPs.] [DOI] [PubMed] [Google Scholar]
  • 35.Yu L, Rostamiani K, Hsu YT, Wang Y, Bi X, Baudry M. Calpain-mediated regulation of stargazin in adult rat brain. Neuroscience. 2011;178:13–20. doi: 10.1016/j.neuroscience.2011.01.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Tomita S, Adesnik H, Sekiguchi M, Zhang W, Wada K, Howe JR, Nicoll RA, Bredt DS. Stargazin modulates AMPA receptor gating and trafficking by distinct domains. Nature. 2005;435:1052–1058. doi: 10.1038/nature03624. [DOI] [PubMed] [Google Scholar]
  • 37.Turetsky D, Garringer E, Patneau DK. Stargazin modulates native AMPA receptor functional properties by two distinct mechanisms. J Neurosci. 2005;25:7438–7448. doi: 10.1523/JNEUROSCI.1108-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Priel A, Kolleker A, Ayalon G, Gillor M, Osten P, Stern-Bach Y. Stargazin reduces desensitization and slows deactivation of the AMPA-type glutamate receptors. J Neurosci. 2005;25:2682–2686. doi: 10.1523/JNEUROSCI.4834-04.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Cho CH, St-Gelais F, Zhang W, Tomita S, Howe JR. Two Families of TARP Isoforms that Have Distinct Effects on the Kinetic Properties of AMPA Receptors and Synaptic Currents. Neuron. 2007;55:890–904. doi: 10.1016/j.neuron.2007.08.024. [DOI] [PubMed] [Google Scholar]
  • 40.Milstein AD, Zhou W, Karimzadegan S, Bredt DS, Nicoll RA. TARP Subtypes Differentially and Dose-Dependently Control Synaptic AMPA Receptor Gating. Neuron. 2007;55:905–918. doi: 10.1016/j.neuron.2007.08.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Soto D, Coombs ID, Kelly L, Farrant M, Cull-Candy SG. Stargazin attenuates intracellular polyamine block of calcium-permeable AMPA receptors. Nat Neurosci. 2007;10:1260–1267. doi: 10.1038/nn1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • *42.Soto D, Coombs ID, Renzi M, Zonouzi M, Farrant M, Cull-Candy SG. Selective regulation of long-form calcium-permeable AMPA receptors by an atypical TARP, gamma-5. Nat Neurosci. 2009;12:277–285. doi: 10.1038/nn.2266. [This paper showed that the type II TARP γ-5 modulates channel properties and calcium permeability of AMPARs.] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • *43.Kristensen AS, Jenkins MA, Banke TG, Schousboe A, Makino Y, Johnson RC, Huganir R, Traynelis SF. Mechanism of Ca2+/calmodulin-dependent kinase II regulation of AMPA receptor gating. Nat Neurosci. 2011;14:727–735. doi: 10.1038/nn.2804. [This paper showed that TARP could modulate AMPAR conductance in an AMPAR phosphorylation-dependent manner.] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Tomita S, Byrd RK, Rouach N, Bellone C, Venegas A, O'Brien JL, Kim KS, Olsen O, Nicoll RA, Bredt DS. AMPA receptors and stargazin-like transmembrane AMPA receptor-regulatory proteins mediate hippocampal kainate neurotoxicity. Proc Natl Acad Sci U S A. 2007;104:18784–18788. doi: 10.1073/pnas.0708970104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Tomita S, Sekiguchi M, Wada K, Nicoll RA, Bredt DS. Stargazin controls the pharmacology of AMPA receptor potentiators. Proc Natl Acad Sci U S A. 2006;103:10064–10067. doi: 10.1073/pnas.0603128103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Montgomery KE, Kessler M, Arai AC. Modulation of agonist binding to AMPA receptors by 1-(1,4-benzodioxan-6-ylcarbonyl)piperidine (CX546): differential effects across brain regions and GluA1-4/transmembrane AMPA receptor regulatory protein combinations. J Pharmacol Exp Ther. 2009;331:965–974. doi: 10.1124/jpet.109.158014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Menuz K, Stroud RM, Nicoll RA, Hays FA. TARP Auxiliary Subunits Switch AMPA Receptor Antagonists into Partial Agonists. Science. 2007;318:815–817. doi: 10.1126/science.1146317. [DOI] [PubMed] [Google Scholar]
  • 48.Lee SH, Govindaiah G, Cox CL. Selective excitatory actions of DNQX and CNQX in rat thalamic neurons. J Neurophysiol. 2010;103:1728–1734. doi: 10.1152/jn.00540.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Tomita S, Shenoy A, Fukata Y, Nicoll RA, Bredt DS. Stargazin interacts functionally with the AMPA receptor glutamate-binding module. Neuropharmacology. 2007;52:87–91. doi: 10.1016/j.neuropharm.2006.07.012. [DOI] [PubMed] [Google Scholar]
  • 50.Sager C, Terhag J, Kott S, Hollmann M. The C-terminal domains of transmembrane alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor regulatory proteins not only facilitate trafficking but are major modulators of AMPA receptor function. J Biol Chem. 2009 doi: 10.1074/jbc.M109.039891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Milstein AD, Nicoll RA. TARP modulation of synaptic AMPA receptor trafficking and gating depends on multiple intracellular domains. Proc Natl Acad Sci U S A. 2009;106:11348–11351. doi: 10.1073/pnas.0905570106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Jackson AC, Milstein AD, Soto D, Farrant M, Cull-Candy SG, Nicoll RA. Probing TARP modulation of AMPA receptor conductance with polyamine toxins. J Neurosci. 2011;31:7511–7520. doi: 10.1523/JNEUROSCI.6688-10.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Morimoto-Tomita M, Zhang W, Straub C, Cho CH, Kim KS, Howe JR, Tomita S. Autoinactivation of neuronal AMPA receptors via glutamate-regulated TARP interaction. Neuron. 2009;61:101–112. doi: 10.1016/j.neuron.2008.11.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • **54.Kato AS, Gill MB, Ho MT, Yu H, Tu Y, Siuda ER, Wang H, Qian YW, Nisenbaum ES, Tomita S, et al. Hippocampal AMPA receptor gating controlled by both TARP and cornichon proteins. Neuron. 2010;68:1082–1096. doi: 10.1016/j.neuron.2010.11.026. [This paper first showed that CNIHs forms a tripartite complex with AMPAR and TARPs, and indeed hippocampal AMPAR contains both TARP γ-8 and CNIHs to control its gating.] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Gill MB, Kato AS, Roberts MF, Yu H, Wang H, Tomita S, Bredt DS. Cornichon-2 modulates AMPA receptor-transmembrane AMPA receptor regulatory protein assembly to dictate gating and pharmacology. J Neurosci. 2011;31:6928–6938. doi: 10.1523/JNEUROSCI.6271-10.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • **56.Shi Y, Suh YH, Milstein AD, Isozaki K, Schmid SM, Roche KW, Nicoll RA. Functional comparison of the effects of TARPs and cornichons on AMPA receptor trafficking and gating. Proc Natl Acad Sci U S A. 2010;107:16315–16319. doi: 10.1073/pnas.1011706107. [This paper showed that CNIHs can slow decay kinetics of AMPAR/γ-8 in heterologous cells, but not in neurons expressing γ-2.] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Schober DA, Gill MB, Yu H, Gernert DL, Jeffries MW, Ornstein PL, Kato AS, Felder CC, Bredt DS. Transmembrane AMPA receptor regulatory proteins and cornichon-2 allosterically regulate AMPA receptor antagonists and potentiators. J Biol Chem. 2011;286:13134–13142. doi: 10.1074/jbc.M110.212522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Shi Y, Lu W, Milstein AD, Nicoll RA. The stoichiometry of AMPA receptors and TARPs varies by neuronal cell type. Neuron. 2009;62:633–640. doi: 10.1016/j.neuron.2009.05.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Kim KS, Yan D, Tomita S. Assembly and stoichiometry of the AMPA receptor and transmembrane AMPA receptor regulatory protein complex. J Neurosci. 2010;30:1064–1072. doi: 10.1523/JNEUROSCI.3909-09.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Vandenberghe W, Nicoll RA, Bredt DS. Stargazin is an AMPA receptor auxiliary subunit. Proc Natl Acad Sci U S A. 2005;102:485–490. doi: 10.1073/pnas.0408269102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Castillo PE, Malenka RC, Nicoll RA. Kainate receptors mediate a slow postsynaptic current in hippocampal CA3 neurons. Nature. 1997;388:182–186. doi: 10.1038/40645. [DOI] [PubMed] [Google Scholar]
  • 62.Vignes M, Collingridge GL. The synaptic activation of kainate receptors. Nature. 1997;388:179–182. doi: 10.1038/40639. [DOI] [PubMed] [Google Scholar]
  • 63.Foster AC, Mena EE, Monaghan DT, Cotman CW. Synaptic localization of kainic acid binding sites. Nature. 1981;289:73–75. doi: 10.1038/289073a0. [DOI] [PubMed] [Google Scholar]
  • **64.Zhang W, St-Gelais F, Grabner CP, Trinidad JC, Sumioka A, Morimoto-Tomita M, Kim KS, Straub C, Burlingame AL, Howe JR, et al. A transmembrane accessory subunit that modulates kainate-type glutamate receptors. Neuron. 2009;61:385–396. doi: 10.1016/j.neuron.2008.12.014. [This paper first identified Neto2 as kainate receptor binding protein, and showed that Neto2 slows decay kinetics of KARs and KARs enhance Neto2 surface expression.] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Copits BA, Robbins JS, Frausto S, Swanson GT. Synaptic Targeting and Functional Modulation of GluK1 Kainate Receptors by the Auxiliary Neuropilin and Tolloid-Like (NETO) Proteins. J Neurosci. 2011;31:7334–7340. doi: 10.1523/JNEUROSCI.0100-11.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Straub C, Zhang W, Howe JR. Neto2 modulation of kainate receptors with different subunit compositions. J Neurosci. 2011;31:8078–8082. doi: 10.1523/JNEUROSCI.0024-11.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • **67.Straub C, Hunt DL, Yamasaki M, Kim KS, Watanabe M, Castillo PE, Tomita S. Distinct functions of kainate receptors in the brain are determined by the auxiliary subunit Neto1. Nat Neurosci. 2011;14:866–873. doi: 10.1038/nn.2837. [This paper showed that distinct slow kinetics of KAR-EPSCs and distinct localization of KAR labeled with [3H] kainate are determined by Neto1 in hippocampus.] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • *68.Tang M, Pelkey KA, Ng D, Ivakine E, McBain CJ, Salter MW, McInnes RR. Neto1 Is an Auxiliary Subunit of Native Synaptic Kainate Receptors. J Neurosci. 2011;31:10009–10018. doi: 10.1523/JNEUROSCI.6617-10.2011. [This paper showed that distinct slow kinetics of KAR-EPSCs is controlled by Neto1 in hippocampus.] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Mulle C, Sailer A, Perez-Otano I, Dickinson-Anson H, Castillo PE, Bureau I, Maron C, Gage FH, Mann JR, Bettler B, et al. Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice. Nature. 1998;392:601–605. doi: 10.1038/33408. [DOI] [PubMed] [Google Scholar]

RESOURCES